Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synova Life Sciences has developed the Synova WAVE device, which enables rapid, high-yield extraction of viable adipose-derived stem cells from fat tissue. The technology reduces processing time from hours to minutes and produces a higher number of healthier cells compared to traditional methods. The company is pursuing applications in regenerative medicine and has announced plans for an IND filing targeting neuroinflammatory disorders related to suicide risk in collaboration with Therapeutic Solutions International. No published clinical results as of June 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synova Life Sciences.